• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DT-黄递酶的研究进展——催化特性、活性调节及其在外源化合物解毒中的意义

Advances in research on DT-diaphorase--catalytic properties, regulation of activity and significance in the detoxication of foreign compounds.

作者信息

Horie S

机构信息

Department of Biochemistry, School of Medicine, Kitasato University, Kanagawa, Japan.

出版信息

Kitasato Arch Exp Med. 1990 Apr;63(1):11-30.

PMID:2125671
Abstract

DT-diaphorase [NAD(P)H dehydrogenase (quinone), EC 1.6.99.2] is a flavoprotein enzyme widely distributed in the cytosolic fractions of various animal tissues. It is also called menadione reductase or NAD(P)H-quinone reductase and catalyzes NAD(P)H-dependent 1-, 2- or 4-electron reduction of certain redox dyes, aromatic nitro compounds, aromatic C-nitroso compounds and probably azo-dyes, as well as menadione (vitamin K3) and other quinones. Dicumarol exerts characteristic inhibition on DT-diaphorase, whereas serum albumin and certain non-ionic detergents exert activation. Excessive concentrations of many of the electron acceptors inhibit the activity of this enzyme. The physiological significance of DT-diaphorase is still obscure because the physiological vitamins (K1 and K2) and coenzyme Q10 are difficult to reduce with this enzyme. Results of recent studies suggest that DT-diaphorase prevents formation of active oxygen species. Activities in liver and other tissues are known to be enhanced by administration of chemicals including certain carcinogens such as 3-methylcholanthrene (3-MC), anti-oxidants such as 3-tert-butyl-4-hydroxyanisole (BHA), and other compounds. Both basal and induced activities vary considerably with tissue, sex, strain and species of animals. The strain variations in activities in rat and mouse liver are known to be inherited, and the trait of hereditary transmission can be adequately explained by postulating two loci of genes or gene clusters regulating the activity. Resistance of animals to various toxic or carcinogenic substances may be promoted by BHA administration and depressed by dicumarol administration. Thus, attention has been focused on the role played by DT-diaphorase in the detoxication of foreign compounds. Knowledge on strain variations in basal and induced activities of tissue DT-diaphorase is of potential value when choosing a rat or mouse strain suitable for studying the toxic effects of drugs, especially drugs expected to be detoxified by reductive metabolism. With future progress in research on DT-diaphorase, this enzyme might be applied to prophylactic and therapeutic medicine.

摘要

DT-黄递酶[NAD(P)H脱氢酶(醌),EC 1.6.99.2]是一种黄素蛋白酶,广泛分布于各种动物组织的胞质部分。它也被称为甲萘醌还原酶或NAD(P)H-醌还原酶,催化某些氧化还原染料、芳香族硝基化合物、芳香族亚硝基化合物以及可能的偶氮染料、甲萘醌(维生素K3)和其他醌类的NAD(P)H依赖性1-、2-或4-电子还原反应。双香豆素对DT-黄递酶有特异性抑制作用,而血清白蛋白和某些非离子去污剂则有激活作用。许多电子受体的过量浓度会抑制该酶的活性。DT-黄递酶的生理意义仍不清楚,因为生理性维生素(K1和K2)和辅酶Q10很难被该酶还原。最近的研究结果表明,DT-黄递酶可防止活性氧的形成。已知通过给予包括某些致癌物如3-甲基胆蒽(3-MC)、抗氧化剂如3-叔丁基-4-羟基茴香醚(BHA)等化学物质以及其他化合物,可增强肝脏和其他组织中的活性。基础活性和诱导活性在不同组织、性别、动物品系和物种之间有很大差异。已知大鼠和小鼠肝脏中活性的品系差异是可遗传的,通过假定两个调节活性的基因位点或基因簇可以充分解释遗传传递的特征。给予BHA可促进动物对各种有毒或致癌物质的抗性,而给予双香豆素则会降低这种抗性。因此,人们将注意力集中在DT-黄递酶在对外源化合物解毒中的作用上。当选择适合研究药物尤其是预期通过还原代谢解毒的药物的毒性作用的大鼠或小鼠品系时,了解组织DT-黄递酶基础活性和诱导活性的品系差异具有潜在价值。随着DT-黄递酶研究的未来进展,这种酶可能会应用于预防医学和治疗医学。

相似文献

1
Advances in research on DT-diaphorase--catalytic properties, regulation of activity and significance in the detoxication of foreign compounds.DT-黄递酶的研究进展——催化特性、活性调节及其在外源化合物解毒中的意义
Kitasato Arch Exp Med. 1990 Apr;63(1):11-30.
2
Kinetics of glutathione transferase, glutathione transferase messenger RNA, and reduced nicotinamide adenine dinucleotide (phosphate):quinone reductase induction by 2(3)-tert-butyl-4-hydroxyanisole in mice.2(3)-叔丁基-4-羟基茴香醚对小鼠谷胱甘肽转移酶、谷胱甘肽转移酶信使核糖核酸及还原型烟酰胺腺嘌呤二核苷酸(磷酸):醌还原酶的诱导动力学
Cancer Res. 1984 Nov;44(11):5256-61.
3
Mouse strain variations in the magnitude of induction of liver DT-diaphorase and hereditary transmission of the trait.
Comp Biochem Physiol B. 1989;93(2):493-8. doi: 10.1016/0305-0491(89)90112-0.
4
Role of Nad(P)h: quinone oxidoreductase in the regulation of intracellular redox state.烟酰胺腺嘌呤二核苷酸磷酸(Nad(P)h):醌氧化还原酶在细胞内氧化还原状态调节中的作用。
Rom J Intern Med. 2000;38-39:33-50.
5
Rat strain variations in liver cytosolic DT-diaphorase activity and possible significance of the trait in carcinogenesis by azo dyes.
Comp Biochem Physiol B. 1989;94(4):673-7. doi: 10.1016/0305-0491(89)90148-x.
6
Prominent role of DT-diaphorase as a cellular mechanism reducing chromium(VI) and reverting its mutagenicity.DT-黄递酶作为一种降低六价铬并逆转其致突变性的细胞机制的重要作用。
Cancer Res. 1985 Jul;45(7):3188-96.
7
Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.NAD(P)H:醌氧化还原酶-2(NQO2)的催化特性,一种依赖二氢烟酰胺核糖苷的氧化还原酶。
Arch Biochem Biophys. 1997 Nov 15;347(2):221-8. doi: 10.1006/abbi.1997.0344.
8
The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.功能基团对DT-黄递酶还原和激活醌类生物还原剂的影响。
Cancer Chemother Pharmacol. 2002 Feb;49(2):101-10. doi: 10.1007/s00280-001-0395-1. Epub 2001 Nov 24.
9
Induction of DT-diaphorase in cancer chemoprevention and chemotherapy.DT-黄递酶在癌症化学预防和化疗中的诱导作用。
Oncol Res. 1997;9(6-7):371-82.
10
p-nitrosophenol reduction by liver cytosol from ADH-positive and -negative deermice (Peromyscus maniculatus).用来自乙醇脱氢酶阳性和阴性鹿鼠(草原鹿鼠)的肝细胞溶胶对亚硝基苯酚进行还原反应。
Arch Biochem Biophys. 1995 Feb 1;316(2):879-85. doi: 10.1006/abbi.1995.1118.

引用本文的文献

1
Avoiding Fluorescence Assay Interference-The Case for Diaphorase.避免荧光测定干扰——黄递酶的情况
Assay Drug Dev Technol. 2016 Apr;14(3):175-9. doi: 10.1089/adt.2016.707.
2
Transfection of COS-1 cells with DT-diaphorase cDNA: role of a base change at position 609.用DT-黄递酶cDNA转染COS-1细胞:609位碱基变化的作用
Br J Cancer. 1998 Apr;77(8):1236-40. doi: 10.1038/bjc.1998.208.